Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni

被引:29
作者
O'Ryan, Miguel [1 ]
Vidal, Roberto [1 ]
del Canto, Felipe [1 ]
Carlos Salazar, Juan [1 ]
Montero, David [1 ]
机构
[1] Univ Chile, Fac Med, Microbiol & Mycol Program, Inst Biomed Sci, Santiago 7, Chile
关键词
acute diarrhea; Campylobacter; E; coli; ETEC; enteric pathogens; gastroenteritis; norovirus; rotavirus; Shigella; Salmonella; STEC; V; cholera; vaccines; O-SPECIFIC POLYSACCHARIDE; HEAT-LABILE TOXIN; HEMOLYTIC-UREMIC SYNDROME; WHOLE-CELL VACCINE; DYSENTERIAE TYPE-1 VACCINE; PROTEIN CONJUGATE VACCINE; PLACEBO-CONTROLLED TRIAL; B-SUBUNIT VACCINE; GUINEA-PIG MODEL; ESCHERICHIA-COLI;
D O I
10.1080/21645515.2015.1011578
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In Part II we discuss the following bacterial pathogens: Shigella, Salmonella (non-typhoidal), diarrheogenic E. coli (enterotoxigenic and enterohemorragic) and Campylobacter jejuni. In contrast to the enteric viruses and Vibrio cholerae discussed in Part I of this series, for the bacterial pathogens described here there is only one licensed vaccine, developed primarily for Vibrio cholerae and which provides moderate protection against enterotoxigenic E. coli (ETEC) (Dukoral (R)), as well as a few additional candidates in advanced stages of development for ETEC and one candidate for Shigella spp. Numerous vaccine candidates in earlier stages of development are discussed.
引用
收藏
页码:601 / 619
页数:19
相关论文
共 195 条
[1]   Bacterial outer membrane vesicles and vaccine applications [J].
Acevedo, Reinaldo ;
Fernandez, Sonsire ;
Zayas, Caridad ;
Acosta, Armando ;
Elena Sarmiento, Maria ;
Ferro, Valerie A. ;
Rosenqyise, Einar ;
Campal, Concepcion ;
Cardoso, Daniel ;
Garcia, Luis ;
Luis Perez, Jose .
FRONTIERS IN IMMUNOLOGY, 2014, 5
[2]   Detection of intimins α, β, γ, and δ, four intimin derivatives expressed by attaching and effacing microbial pathogens [J].
Adu-Bobie, J ;
Frankel, G ;
Bain, C ;
Goncalves, AG ;
Trabulsi, LR ;
Douce, G ;
Knutton, S ;
Dougan, G .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (03) :662-668
[3]   Safety and immunogenicity of Escherichia coli O157O-specific polysaccharide conjugate vaccine in 2-5-year-old children [J].
Ahmed, A ;
Li, JP ;
Shiloach, Y ;
Robbins, JB ;
Szu, SC .
JOURNAL OF INFECTIOUS DISEASES, 2006, 193 (04) :515-521
[4]  
Ahmed T., 2013, COCHRANE DB SYST REV, V7
[5]   Salmonella enterica Serovar Typhimurium Lacking hfq Gene Confers Protective Immunity against Murine Typhoid [J].
Allam, Uday Shankar ;
Krishna, M. Gopala ;
Lahiri, Amit ;
Joy, Omana ;
Chakravortty, Dipshikha .
PLOS ONE, 2011, 6 (02)
[6]   Immunogenic properties of chimeric protein from espA, eae and tir genes of Escherichia coli O157:H7 [J].
Amani, Jafar ;
Salmanian, Ali Hatef ;
Rafati, Sima ;
Mousavi, Seyed Latif .
VACCINE, 2010, 28 (42) :6923-6929
[7]  
[Anonymous], 2013, OR CHOL VACC STOCKP
[8]   Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children [J].
Ashkenazi, S ;
Passwell, JH ;
Harlev, E ;
Miron, D ;
Dagan, R ;
Farzan, N ;
Ramon, R ;
Majadly, F ;
Bryla, DA ;
Karpas, AB ;
Robbins, JB ;
Schneerson, R .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (06) :1565-1568
[9]   Serological Response of Shiga Toxin-Producing Escherichia coli Type III Secreted Proteins in Sera from Vaccinated Rabbits, Naturally Infected Cattle, and Humans [J].
Asper, David J. ;
Karmali, Mohamed A. ;
Townsend, Hugh ;
Rogan, Dragan ;
Potter, Andrew A. .
CLINICAL AND VACCINE IMMUNOLOGY, 2011, 18 (07) :1052-1057
[10]   Subcutaneous and intranasal immunization with type III secreted proteins can prevent colonization and shedding of Escherichia coli O157:H7 in mice [J].
Babiuk, Shawn ;
Asper, David J. ;
Rogan, Dragan ;
Mutwiri, George K. ;
Potter, Andrew A. .
MICROBIAL PATHOGENESIS, 2008, 45 (01) :7-11